Asset Details
Do you wish to reserve the book?
Early inhibition of BRD4 facilitates iPSC reprogramming via accelerating rDNA dynamic expression
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Early inhibition of BRD4 facilitates iPSC reprogramming via accelerating rDNA dynamic expression
Do you wish to request the book?
Early inhibition of BRD4 facilitates iPSC reprogramming via accelerating rDNA dynamic expression
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Early inhibition of BRD4 facilitates iPSC reprogramming via accelerating rDNA dynamic expression
2024
Overview
Background
iPSC reprogramming technology exhibits significant promise in the realms of clinical therapeutics, disease modeling, pharmaceutical drug discovery, and various other applications. However, the extensive utilization of this technology has encountered impediments in the form of inefficiency, prolonged procedures, and ambiguous biological processes. Consequently, in order to improve this technology, it is of great significance to delve into the underlying mechanisms involved in iPSC reprogramming. The BET protein BRD4 plays a crucial role in the late stage of reprogramming; however, its precise function in the early stage remains unclear.
Results
Our study aims to investigate BRD4’s role in the early stages of iPSC reprogramming. Our investigation reveals that early inhibition of BRD4 substantially enhances iPSC reprogramming, whereas its implementation during the middle-late stage impedes the process. During the reprogramming, ribosome DNA expression initially increases before decreasing and then gradually recovers. Early inhibition of BRD4 improved the decline and restoration of rDNA expression in the early and middle-late stages, respectively. Additionally, we uncovered the mechanism of BRD4’s regulation of rDNA transcription throughout reprogramming. Specifically, BRD4 interacts with UBF and co-localizes to both the rDNA promoter and enhancer regions. Ultimately, BRD4 facilitates rDNA transcription by promoting the enrichment of histone H3 lysine 27 acetylation in the surrounding chromatin. Moreover, we also discovered that early inhibition of BRD4 facilitates cells’ transition out of the somatic cell state and activate pluripotent genes.
Conclusions
In conclusion, our results demonstrate that early inhibition of BRD4 promotes sequential dynamic expression of rDNA, which improves iPSC reprogramming efficiency.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject
/ Animals
/ Biomedical and Life Sciences
/ BRD4
/ Bromodomain Containing Proteins
/ Cell Cycle Proteins - genetics
/ Cell Cycle Proteins - metabolism
/ Cells
/ Cellular Reprogramming - genetics
/ H3K27ac
/ Histones
/ Humans
/ Induced Pluripotent Stem Cells - metabolism
/ Lysine
/ Mice
/ Nuclear Proteins - metabolism
/ Proteins
/ RNA
/ Transcription Factors - genetics
/ Transcription Factors - metabolism
/ UBF
